SUMMARY
Sevoflurane, a nonpungent anaesthetic with a low blood gas partition coefficient, is an ideal agent for inhaled induction of anaesthesia and tracheal intubation in paediatric patients. However, tracheal intubation with sevoflurane alone requires a longer time for adequate jaw relaxation 1, 2 , and rapid sevoflurane induction with high inspiratory concentration produces epileptiform electroencephalographic activity in children 3 . Several authors recommend 5% sevoflurane as a safe inspiratory concentration 4, 5 and various anaesthetic adjuvants such as topical lignocaine, intravenous or nasal opioids have been suggested to facilitate tracheal intubation [6] [7] [8] [9] [10] , but the best choice of adjuvant is less clear.
Propofol has been found to more effectively induce jaw relaxation and to suppress upper airway reflexes compared with other intravenous induction agents 11 . Propofol also possesses anticonvulsant activity in children with epilepsy 12 . The combination of propofol and a short-acting opioid during induction of anaesthesia has been found to permit tracheal intubation without the use of neuromuscular blocking agents in paediatric patients [13] [14] [15] . However, little is known about the optimum dose of propofol to facilitate tracheal intubation during sevoflurane inhalational induction 16 . We have therefore undertaken a dose-finding study to determine the optimum propofol dose to produce excellent intubating conditions following inhalational induction of anaesthesia using 5% sevoflurane in 60% nitrous oxide without neuromuscular blocking agents in young children.
METHODS
This study protocol was approved by our institutional review board and written informed consent was obtained from the parents of all patients. Twenty-eight children of American Society of Anesthesiologists physical status I, aged three to seven years, and undergoing short duration elective surgery were recruited. Exclusion criteria included prematurity at birth, high risk of aspiration, signs of upper airway infection or reactive airway disease, suspected difficult airway, obesity (>50% above ideal body weight), or any history of allergy to eggs or soya beans.
No premedication was given. Prior to arrival in the operating room, intravenous access was secured. On arrival in the operating room, routine non-invasive monitoring of blood pressure, electrocardiogram and pulse oximetry (SpO 2 ) were initiated. End-tidal concentration of carbon dioxide and sevoflurane were measured continuously at the elbow of the breathing circuit using a precalibrated gas analyser (Andros 4800 ® , Richmond, CA, USA) at a sampling flow rate of 250 ml/minute. General anaesthesia was induced with a paediatric circle system prefilled with 5% sevoflurane in 60% nitrous oxide and 40% oxygen at a fresh gas flow of 5 l/minute. The circuit was primed using a standard anaesthetic breathing bag and mechanical ventilation, with a fresh gas flow of at least 5 l/minute. Initially, patients breathed spontaneously, and then ventilation was undertaken manually when patients became apnoeic. Two minutes after beginning the anaesthetic induction, a predetermined dose of propofol was injected over 10 seconds. Fifty seconds after the end of bolus administration of propofol, laryngoscopy was performed. The trachea was intubated using a cuffed tracheal tube.
The dose of propofol was determined by the response of the previously tested patient using the Dixon's up-and-down method (using 0.5 mg/kg as a step size). The first patient received 3.0 mg/kg of propofol. Intubation was performed by an experienced anaesthesiologist blinded to the dose of propofol, and intubating conditions were evaluated with five variables (Table 1) 17 . Excellent intubating conditions were defined as a score of 1 for all variables. In the implementation of Dixon's up-and-down dose-finding method this was defined as a positive response. A score of 2 or 3 in any response category was defined as a negative response, and resulted in an increased dose for the next subject. After a patient had excellent conditions, the dose of propofol was reduced for the successive subjects, until a patient had a negative response. Jaw relaxation and vocal cord conditions were evaluated by the anaesthesiologist who performed intubation, and the degree of coughing and limb movement was evaluated by assistants who were unaware of the nature of the study. The assistants were experienced anaesthesia residents educated about the scoring of intubating conditions. If intubation was impossible because of closed vocal cords, patient movement or inadequate jaw relaxation, rocuronium 0.3 mg/kg was administered.
Blood pressure, heart rate and SpO 2 were monitored at baseline (prior to induction of anaesthesia), before and then immediately after tracheal intubation. End-tidal sevoflurane concentration was recorded immediately before and after intubation. Time to loss of consciousness was defined as the time from commencement of sevoflurane administration to loss of the eyelash reflex, and the time for intubation was defined as the interval between removal of the face mask and inflation of the cuff.
Statistical analyses were performed using SPSS 12.0 for Windows (SPSS Inc., Chicago, IL, USA). Data were collected from 28 patients using Dixon's method to provide seven pairs of data where an increase in propofol dose changed a negative response to a positive response in successive patients. The dose of propofol at which there was a 50% probability of excellent intubating conditions was defined as the ED 50 , and was determined by calculating the mean of the midpoint concentration of the seven pairs of data described above. ED 50 and ED 95 with 95% confidence intervals (CI) were also determined using probit analysis. Repeated measures of analysis of variance with post hoc Holm-Sidak method was used to analyse the haemodynamic data. A P value <0.05 was considered statistically significant.
RESULTS
Twenty-eight patients were enrolled in this study. The demographic data and induction profiles are given in Table 2 . The intubation responses for each consecutive patient, using a Dixon's up-and-down sequence, are shown in Figure 1 . Intubating conditions were excellent (score 1 in all variables) Figure 2 ). Patient haemodynamic data are shown in Table 3 . Mean arterial blood pressure prior to intubation was significantly decreased compared with baseline value (P <0.001), and after tracheal intubation blood pressure returned to baseline value. Heart rate was increased significantly before and after tracheal intubation compared with baseline (P=0.025, P <0.001, respectively). No patient experienced clinically significant hypotension or bradycardia requiring treatment. No patient suffered adverse respiratory events such as laryngospasm or bronchospasm, and SpO 2 remained above 90% in all patients throughout the study.
DISCUSSION
Propofol, an intravenous sedative-hypnotic agent with a modulating action on the γ-aminobutyric acid A receptor, interacts with sevoflurane in a simple additive manner to produce sedation and immobility during surgical stimulation. Several studies have shown that a bolus dose of propofol facilitates airway manipulation during inhalational induction. In adults, the combination of sevoflurane and low-dose propofol (1.5 mg/kg) provided the most frequent successful laryngeal mask airway insertion at first attempt compared with induction of anaesthesia with either sevoflurane or propofol alone 18 . Hansen et al 19 obtained 94 to 100% acceptable intubating conditions in young children using a combination of halothane and propofol (3 mg/kg), and Lerman et al 16 demonstrated that propofol 3 mg/kg 30 seconds before laryngoscopy provided superior intubating conditions compared with 0 and 0.5 mg/kg propofol in children during 8% sevoflurane/nitrous oxide anaesthesia. Inhalational induction of anaesthesia with 8% sevoflurane can produce electroencephalographic seizure activity in nonepileptic children 3 , and increase epileptic activity in epileptic children 20 . We therefore sought to determine the dose of propofol that could achieve excellent intubating conditions when combined with 5% sevoflurane instead of 8%. We chose 60% nitrous oxide as a carrier gas for the inhaled sevoflurane to accelerate the rate of onset of anaesthesia and to reduce the requirement for propofol. It is known that 66% nitrous oxide during inhalation induction decreases the concentration of sevoflurane needed to perform tracheal intubation by 40% in children 2 . During 5% sevoflurane induction, the addition of potent short-acting opioids has been used to facilitate tracheal intubation without neuromuscular blockade in paediatric patients. The intravenous bolus doses (ED 95 ) of remifentanil and alfentanil required for good-to-excellent intubating conditions were 0.75 µg/kg and 14.0 µg/kg respectively three minutes after inhalational induction with 5% sevoflurane in oxygen 7, 8 . Verghese et al 9 reported that nasal administration of remifentanil 4 µg/kg provided acceptable conditions for intubation in 91.7% of children three minutes after 5% sevoflurane inhalation. However, bolus administration of opioid medication during sevoflurane inhalation induction can be associated with severe bradycardia and even asystole 21 , leading to the need for anticholinergic drugs as prophylaxis. In this study there were no episodes of clinically significant bradycardia or hypotension, probably due to the relatively low doses of propofol and sympathetic stimulation of nitrous oxide. Moreover, propofol is less expensive than opioids in most countries, providing another advantage of bolus propofol over opioids 22, 23 . In the present study, excellent intubating conditions were sought because they are less frequently associated with postoperative hoarseness and vocal cord sequelae 24 . In requiring excellent conditions to score the positive response in our upand-down analysis, we eliminated potential variation in the observers' grading of response, because no qualitative judgement was required. We performed laryngoscopy three minutes after the start of sevoflurane inhalation. This time was comparable to similar studies, but the mean end-tidal sevoflurane concentration we observed (3.9%) was slightly higher than previously observed (3.3 to 3.4%) using 5% sevoflurane induction 7, 8 . These differences in end-tidal sevoflurane concentration may be attributed to the differences in degree of priming of anaesthetic circuits before induction and in the ventilation strategies used.
The timing of tracheal intubation in relation to the time of peak propofol effect could affect the intubating conditions. Tracheal intubation was attempted 50 seconds after the propofol bolus and completed within about 16.5 seconds, and this coincides with the peak effect previously described with bispectral index 25 . None of our patients showed withdrawal movements during propofol injection, probably due to the sufficient anaesthetic depth of inhaled sevoflurane and nitrous oxide prior to propofol administration.
This study has several limitations. First, propofol requirement varies in children according to age, although a single dose of propofol is recommended for induction of anaesthesia in the age groups of the current study 26 . Aun et al 27 reported that younger patients required higher doses of propofol for anaesthetic induction. Second, the wide CI for ED 95 found suggests that some patients may need a propofol dose outside the usual clinical range, and this is unsafe. The wide 95% CI for ED 95 is attributable to individual variability and the small sample size, and further investigation into the variability of dose response with a larger sample size is warranted to enable safe recommendations to be developed. In addition, because a propofol bolus can provoke significant hypotension in patients who are hypovolaemic or have limited cardiovascular reserve, especially when combined with inhaled sevoflurane during induction, the technique is only recommended for fit and healthy patients.
In conclusion, the optimum bolus dose of propofol for excellent intubation conditions was 1.39 mg/kg in 50% of children during 5% sevoflurane and 60% nitrous oxide inhalation induction without a neuromuscular blocking agent. This method provides an alternative pharmacological method for facilitating tracheal intubation to the traditional approach using opioids or neuromuscular blocking drugs in paediatric patients.
